BREAKING NEWS: HHS Secretary Kennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2 and advancing them for formal review. FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies FDA Peptide Update: Category 2 Removals Explained Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health